Key facts
- This page summarizes Philip Wheatley's Form 4 filing for CRH PUBLIC LTD CO (CRH).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 05 Mar 2025, 16:30.
Philip Wheatley - 03 Mar 2025 Form 4 Insider Report for CRH PUBLIC LTD CO (CRH)
- Reporting relationship
- Chief Growth Officer
- Issuer ticker
- CRH
- Reported as of
- 03 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Mar 2025, 16:30:19 UTC
- Prior SEC filing
- 02 Jan 2025
- Next SEC filing
- 15 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Cot Eversole, Attorney-in-Fact for Philip Wheatley
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Philip Wheatley filed Form 4 for CRH PUBLIC LTD CO (CRH) on 05 Mar 2025.
Change
- Previous filing in this sequence was filed on 02 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRH
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 37,436
- Date
- 03 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRH
transaction
Derivative
Deferred Share Award
Award
- Transaction value
- Shares
- +2,317
- Change %
- Price
- Shares after
- 2,317
- Date
- 03 Mar 2025
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 2,317
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Includes 128 Ordinary Shares purchased by AC Employee Benefit Trustees Limited, as trustee for and on behalf of the Reporting Person, as sole beneficiary, pursuant to an Irish Revenue-approved broad-based employee share participation scheme. Such Ordinary Shares are subject to a minimum holding requirement of one year.
Footnote F2
Reflects time-based conditional awards, as defined in the 2014 Deferred Share Bonus Plan (the "DSB Plan Rules"), of which, subject to the determination of the Compensation Committee of the Board of Directors of the Issuer, the balance will vest in March 2028. In accordance with the DSB Plan Rules, dividend equivalents will apply to the Award and, to the extent awarded, will be reported at the time of vesting.